Vintage Bad Blood
English, John CarreyrouIn Detail
The Financial Times and McKinsey Book of the Year
A remarkable book from The New York Times
A remarkable book from The Washington Post
One of the best books of the year: NPR, San Francisco Chronicle, Time, Esquire, Fortune, Marie Claire, GQ, Mental Floss, Science Friday, Bloomberg, Popular Mechanics, BookRiot, The Seattle Times, The Oregonian, Publishers Weekly, Library Journal
In 2014, Elizabeth Holmes, the founder and CEO of Theranos, was widely regarded as the next Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with its groundbreaking device that could perform a whole range of lab tests from a single drop of blood. Backed by investors like Larry Ellison and Tim Draper, Theranos sold shares in a funding round that valued the company at over $9 billion, giving Holmes an estimated fortune of $4.5 billion. There was just one problem: the technology didn’t work. Faulty results put patients at risk, leading to misdiagnoses and unnecessary treatments. Meanwhile, Holmes and her partner, Sunny Balwani, worked to silence anyone who raised concerns – from journalists to their own employees.
Meticulously researched and fearlessly written, Bad Blood is a gripping tale of the biggest corporate fraud since Enron – a narrative of ambition and hubris, embedded in the bold promises of Silicon Valley.